Levodopa / carbidopa
Antiparkinsonian (dopamine precursor)
Brand names: Sinemet
Oral health effects
Xerostomia (dry mouth)
Dry mouth is common; some patients instead have drooling from impaired swallowing.
Clinical management: Hydration, salivary substitutes, high-fluoride caries prevention.
Orofacial dyskinesia
Involuntary tongue/jaw movements can occur and complicate dental treatment.
Clinical management: Schedule when medication control is optimal; document movements; support hygiene.
Dark-colored saliva
Saliva (and urine or sweat) can turn red, brown or black after taking carbidopa-levodopa; the label notes this is harmless.
Clinical management: Reassure the patient that dark saliva is a known harmless drug effect and not bleeding or staining from a dental cause; it may tint plaque or tongue coating, so do not mistake it for extrinsic stain or blood.
Taste change and burning tongue
The label lists taste alterations and a burning sensation of the tongue; bruxism and sialorrhea are also reported.
Clinical management: Ask about altered or metallic taste, which can reduce appetite and oral comfort; reassure that it is drug-related and often fades. Rule out oral candidiasis or poor hygiene as contributors and encourage sugar-free options rather than sweet foods/drinks used to mask the taste. Burning tongue is uncommon; exclude candidiasis, nutritional deficiency and denture problems first.
Sources
- A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Wolff A, Joshi RK, Ekström J, et al. Drugs in R&D, 2017.
- A review and guide to drug-associated oral adverse effects-Dental, salivary and neurosensory reactions. Part 1. Teoh L, Moses G, McCullough MJ. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2019.
- Levodopa / carbidopa prescribing information (FDA label) Bryant Ranch Prepack / DailyMed, 2026.